Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Treasury Shares (2023 - 2025)

Historic Treasury Shares for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $525350.0.

  • Zenas BioPharma's Treasury Shares changed N/A to $525350.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $525350.0, marking a year-over-year change of. This contributed to the annual value of $21172.0 for FY2024, which is 2216.18% down from last year.
  • As of Q3 2025, Zenas BioPharma's Treasury Shares stood at $525350.0.
  • Zenas BioPharma's 5-year Treasury Shares high stood at $525350.0 for Q3 2025, and its period low was $21172.0 during Q1 2024.
  • Moreover, its 3-year median value for Treasury Shares was $27200.0 (2023), whereas its average is $221198.8.
  • Data for Zenas BioPharma's Treasury Shares shows a peak YoY increase of 2216.18% (in 2024) and a maximum YoY decrease of 2216.18% (in 2024) over the last 5 years.
  • Over the past 3 years, Zenas BioPharma's Treasury Shares (Quarter) stood at $27200.0 in 2023, then decreased by 22.16% to $21172.0 in 2024, then skyrocketed by 2381.34% to $525350.0 in 2025.
  • Its Treasury Shares stands at $525350.0 for Q3 2025, versus $511100.0 for Q2 2025 and $21172.0 for Q4 2024.